H.C. Wainwright Downgrades EyePoint Pharmaceuticals to Neutral

H.C. Wainwright downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) from Buy to Neutral.

Benzinga · 11/11/2019 12:27

H.C. Wainwright downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) from Buy to Neutral.